Skip to main content
Earnings Labs
Genmab A/S logo

Genmab A/S (GMAB) Earnings Dates & History

NASDAQ·Healthcare·Biotechnology

$25.10

-0.57%

Mkt Cap $16.79B

EPS — Estimate vs Actual

Quarterly History

Q1 2026

Feb 17, 2026

$1.07B$1.06B-0.76%$0.46$0.05-89.13%
Q4 2025

Nov 6, 2025

$1.01B$1.02B+1.08%$0.48$0.65+35.42%
Q3 2025

Aug 7, 2025

$952.56M$924.81M-2.91%$0.39$0.54+38.46%
Q2 2025

May 8, 2025

$755.47M$725.99M-3.90%$0.23$0.31+34.78%
Q1 2025

Feb 12, 2025

$791.87M$891.43M+12.57%$0.28$0.57+103.57%
Q4 2024

Nov 6, 2024

$809.62M$815.16M+0.68%$0.35$0.29-17.14%
Q3 2024

Aug 8, 2024

$679.43M$777.83M+14.48%$0.29$0.22-24.14%
Q2 2024

May 2, 2024

$530.81M$594.93M+12.08%$0.16$0.16+0.00%
Q1 2024

Feb 14, 2024

$671.21M$690.33M+2.85%$0.34$0.36+5.88%
Q4 2023

Nov 7, 2023

$642.86M$669.38M+4.13%$3.14$0.47-85.03%
Q3 2023

Aug 3, 2023

$601.13M$613.29M+2.02%$2.18$0.30-86.24%
Q2 2023

May 10, 2023

$404.26M$416.08M+2.92%$0.65$0.05-92.31%
Q1 2023

Feb 22, 2023

$681.42M$754.97M+10.79%$3.15$0.12-96.19%
Q4 2022

Nov 9, 2022

$473.49M$535.64M+13.13%$1.65$0.53-67.88%
Q3 2022

Aug 10, 2022

$412.04M$443.98M+7.75%$1.55$0.41-73.55%
Q2 2022

May 11, 2022

$300.49M$315.14M+4.88%$0.91$0.11-87.91%
Q1 2022

Feb 16, 2022

$389.00M$399.16M+2.61%$5.30$0.17-96.79%
Q4 2021

Nov 10, 2021

$270.35M$360.41M+33.31%$0.11$0.21+90.91%
Q3 2021

Aug 11, 2021

$353.27M$314.36M-11.02%$0.08$0.08+0.00%
Q2 2021

May 5, 2021

$214.32M$249.78M+16.54%$0.23$0.27+17.39%
Q1 2021

Feb 23, 2021

$563.55M$335.62M-40.44%$1.28$0.14-89.06%
Q4 2020

Nov 4, 2020

$459.63M$271.70M-40.89%$0.99$0.13-86.87%
Q3 2020

Aug 12, 2020

$231.81M$822.37M+254.76%$0.88$0.76-13.64%
Q2 2020

May 6, 2020

$763.51M$129.82M-83.00%$0.06$0.06+3.45%
Q1 2020

Feb 19, 2020

$430.54M$449.49M+4.40%$0.36$0.34-5.56%
Q4 2019

Nov 6, 2019

$195.69M$152.42M-22.11%$0.08$1.26+1475.00%
Q3 2019

Aug 20, 2019

$144.85M$117.59M-18.82%$0.27$0.20-25.93%
Q1 2019

Mar 31, 2019

$88.87M$0.02
Q4 2018

Dec 31, 2018

$198.32M$0.22
Q3 2018

Sep 30, 2018

$93.53M$0.05
Q2 2018

Jun 30, 2018

$79.34M$0.07
Q1 2018

Mar 31, 2018

$112.55M$0.05
Q4 2017

Dec 31, 2017

$160.31M$0.20
Q3 2017

Sep 30, 2017

$51.15M-$0.00
Q2 2017

Jun 30, 2017

$118.46M$0.08
Q1 2017

Mar 31, 2017

$36.09M$0.00
Q4 2016

Dec 31, 2016

$130.83M$0.19
Q3 2016

Sep 30, 2016

$54.88M$0.05
Q2 2016

Jun 30, 2016

$52.83M$0.04
Q1 2016

Mar 31, 2016

$25.94M-$0.00
Q4 2015

Dec 31, 2015

$83.80M$0.10
Q3 2015

Sep 30, 2015

$41.68M$0.03
Q2 2015

Jun 30, 2015

$25.83M$0.00
Q1 2015

Mar 31, 2015

$15.51M$0.05
Q4 2014

Dec 31, 2014

$37.57M$0.02
Q3 2014

Sep 30, 2014

$46.03M$0.05
Q2 2014

Jun 30, 2014

$21.18M-$0.01
Q1 2014

Mar 31, 2014

$45.44M$0.03
Q4 2013

Dec 31, 2013

$38.38M$0.02
Q3 2013

Sep 30, 2013

$27.22M$0.00
Q2 2013

Jun 30, 2013

$24.08M-$0.01
Q1 2013

Mar 31, 2013

$27.43M$0.02
Q4 2012

Dec 31, 2012

$28.20M-$0.13
Q3 2012

Sep 30, 2012

$19.99M-$0.02
Q2 2012

Jun 30, 2012

$18.75M-$0.00
Q1 2012

Mar 31, 2012

$16.79M-$0.03
Q4 2011

Dec 31, 2011

$16.28M-$0.02
Q3 2011

Sep 30, 2011

$16.41M-$0.15
Q2 2011

Jun 30, 2011

$16.24M-$0.03
Q1 2011

Mar 31, 2011

$15.76M-$0.05
Q4 2010

Dec 31, 2010

$16.18M-$0.03
Q3 2010

Sep 30, 2010

$39.23M-$0.01
Q2 2010

Jun 30, 2010

$28.27M-$0.03
Q1 2010

Mar 31, 2010

$19.27M-$0.05
Q4 2009

Dec 31, 2009

$37.11M-$0.26
Q3 2009

Sep 30, 2009

$13.50M-$0.04
Q2 2009

Jun 30, 2009

$13.92M-$0.05
Q1 2009

Mar 31, 2009

$44.80M-$0.08